Jonathan D. Krant, MD
NPI 1023165172ActiveIndividual· Internal Medicine, Rheumatology· Peterborough, NH
Internal Medicine, Rheumatology (MD) in Peterborough, New Hampshire, licensed in NH, NY, OH and MA, with an NPI issued in January 2007. Part D covered 396 prescriptions written in 2024, 75% of them generic. Vertex Pharmaceuticals Incorporated was the largest of 9 companies reporting payments in 2025, $3,341 in all, mostly consulting fees.
Overview
| NPI | 1023165172 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Jan 4, 2007 |
| Last updated in NPPES | Aug 12, 2024 |
| Certified by provider | Aug 12, 2024 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Rheumatology Primary | 207RR0500X | 25530 | NH |
| Internal Medicine, Rheumatology | 207RR0500X | 272171 | NY |
| Internal Medicine, Rheumatology | 207RR0500X | 35.134834 | OH |
| Internal Medicine, Rheumatology | 207RR0500X | 79140 | MA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Rheumatology (NH) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 396 · 531 30-day fills |
|---|---|
| Patients | 137 |
| Total drug cost | $564,472 |
| Generic share | 75% of claims |
Industry payments (Open Payments)
- 2025$3,341 · 48 payments from 9 companies
- 2024$10,932 · 47 payments from 11 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | $1,267 | 3 |
| Janssen Biotech, Inc. | $649.25 | 21 |
| Tersera Therapeutics LLC | $580.00 | 1 |
| Ucb, Inc. | $466.05 | 13 |
| Amgen Inc. | $183.73 | 5 |
What the 2025 payments were for
- Consulting Fee$1,847 · 4 payments
- Food and Beverage$1,494 · 44 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records